MP Healthcare Venture Management
Home About Us Portfolio News Contact
HomeAbout UsPortfolioNewsContact
MP Healthcare Venture Management
Genocea Biosciences Initiates Phase 1 Study of Vaccine Candidate Gen-004 to Prevent Infections Caused by Pneumococcus.
Brennan CaruthersDecember 5, 2013
Facebook0 Twitter LinkedIn0 Reddit 0 Likes
Previous

Covagen and Tanabe Research Laboratories Expand Strategic Research Collaboration for Development of Bispecific FynomAbs.

Brennan CaruthersDecember 6, 2013
Next

F-star announces formation of new asset-centric vehicle, F-star Alpha Ltd, with €9.4m Series A investment.

Brennan CaruthersOctober 23, 2013

© 2010-2019 MP Healthcare Venture Management, Inc.
All Rights Reserved.

Privacy Policy | Terms of Use

About UsPortfolioNews Contact